Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
about
Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniaeMinocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic ReviewEarly Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study.Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 yearsTherapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacyCluster of macrolide-resistant Mycoplasma pneumoniae infections in Illinois in 2012.Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia.Mycoplasma pneumoniae from the Respiratory Tract and Beyond.Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic.Mycoplasma pneumoniae: A Potentially Severe Infection.
P2860
Q26744683-B01F13F9-9D01-4779-BB20-159D951D1870Q26771470-EC302B2A-3CA5-4466-9376-327FFE891B27Q34838916-817E04DC-5AA8-4590-A7D2-676E5BA38266Q35782507-F491FEEB-CEA5-4E76-97B3-A885DB27490FQ36306172-021426F5-2CB0-49D5-A461-D02E0055F268Q37263838-ADD87789-6D5D-4A32-93A0-36AD77CBA2E7Q37470551-D3030BA2-4A11-41E7-B9AB-CFC42CE3D20FQ38170557-1C5C4626-8332-4E8F-B0AD-EA9559885B82Q38651308-7554B13B-C200-47A6-8B5C-F56F101DEE52Q39327219-465633AB-4297-4F18-938A-177F7792F815Q39390126-BAC9EF55-D6EA-41B5-9697-8CD838EB61DCQ39424555-BEBFDE78-F27D-4633-BFC1-B6FCA4FD9A54Q41987270-39D9A078-9666-48AB-9871-D05931CB5540Q50047524-29A8C902-88A8-449E-BFC8-5D5213D7C677Q51595534-96D68174-0017-428E-A2B6-FBD76E5CF38EQ51810584-EB0A0E45-BA3F-4D74-96C4-6DB30A0DDF8AQ55314495-7F724189-9D62-4BAD-BA10-5EA110D8CB71
P2860
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Therapeutic efficacy of macrol ...... eumonia in pediatric patients.
@en
type
label
Therapeutic efficacy of macrol ...... eumonia in pediatric patients.
@en
prefLabel
Therapeutic efficacy of macrol ...... eumonia in pediatric patients.
@en
P2093
P2860
P356
P1476
Therapeutic efficacy of macrol ...... eumonia in pediatric patients.
@en
P2093
Atsushi Kato
Eisuke Kondo
Hideto Teranishi
Hiroto Akaike
Kazunobu Ouchi
Kihei Terada
Kozo Kawasaki
Naoyuki Miyashita
P2860
P304
P356
10.1128/AAC.00048-13
P407
P577
2013-03-04T00:00:00Z